New ADHD pill for kids shows promise in Late-Stage trial
Disease control
Completed
This study tested a new medication called CTx-1301 (dexmethylphenidate) for children and teens aged 6 to 17 with ADHD. The goal was to see if the drug reduces ADHD symptoms better than a placebo. 103 participants took either the study drug or a placebo, and researchers measured c…
Phase: PHASE3 • Sponsor: Cingulate Therapeutics • Aim: Disease control
Last updated May 08, 2026 12:00 UTC